• Laboraroty Animal Research
• /
• 제34권4호
• /
• pp.248-256
• /
• 2018

O-2-$^{18}F$-fluoroethyl-l-tyrosine ($[^{18}F]FET$) has been widely used for glioblastomas (GBM) in clinical practice, although evaluation of its applicability in non-clinical research is still lacking. The objective of this study was to examine the value of $[^{18}F]FET$ for treatment evaluation and prognosis prediction of anti-angiogenic drug in an orthotopic mouse model of GBM. Human U87MG cells were implanted into nude mice and then bevacizumab, a representative anti-angiogenic drug, was administered. We monitored the effect of anti-angiogenic agents using multiple imaging modalities, including bioluminescence imaging (BLI), magnetic resonance imaging (MRI), and positron emission tomography-computed tomography (PET/CT). Among these imaging methods analyzed, only $[^{18}F]FET$ uptake showed a statistically significant decrease in the treatment group compared to the control group (P=0.02 and P=0.03 at 5 and 20 mg/kg, respectively). This indicates that $[^{18}F]FET$ PET is a sensitive method to monitor the response of GBM bearing mice to anti-angiogenic drug. Moreover, $[^{18}F]FET$ uptake was confirmed to be a significant parameter for predicting the prognosis of anti-angiogenic drug (P=0.041 and P=0.007, on Days 7 and 12, respectively, on Pearson's correlation; P=0.048 and P=0.030, on Days 7 and 12, respectively, on Cox regression analysis). However, results of BLI or MRI were not significantly associated with survival time. In conclusion, this study suggests that $[^{18}F]FET$ PET imaging is a pertinent imaging modality for sensitive monitoring and accurate prediction of treatment response to anti-angiogenic agents in an orthotopic model of GBM.

• Annals of Coloproctology
• /
• 제34권6호
• /
• pp.286-291
• /
• 2018

Purpose: Stage-IIIC colon cancer is an advanced disease; however, its oncologic outcomes and prognostic factors remain unclear. In this study, we aimed to determine the predictors of disease-free survival (DFS) in patients with stage-IIIC colon cancer. Methods: From a multicenter database, we retrospectively enrolled 611 patients (355 men and 256 women) who had undergone a potentially curative resection for a stage-IIIC colon adenocarcinoma between 2003 and 2011. The primary endpoint was the 5-year DFS. Results: The median age was 62 years; 213 and 398 patients had right-sided colon cancer (RCC) and left-sided colon cancer (LCC), respectively. The 5-year DFS in all patients was 52.0%; median follow-up time was 35 months (range, 1-134 months). A multivariate Cox regression revealed that female sex (hazard ratio [HR], 1.50; 95% confidence interval [CI], 1.19-1.90; P < 0.01), right-sided tumor location (HR, 1.65; 95% CI, 1.29-2.11; P < 0.01), lymphatic invasion (HR, 1.52; 95% CI, 1.08-2.15; P < 0.01) and a high (${\geq}0.4$) metastatic lymph node ratio (HR, 3.72; 95% CI, 2.63-5.24; P < 0.01) were independent predictors of worse 5-year DFS. Female patients with RCC were 1.79 fold more likely to experience recurrence than male patients with LCC. Conclusion: Female sex and right-sided tumor location are associated with higher tumor recurrence rates in patients with stage-IIIC colon cancers. Aggressive treatment and close surveillance should be planned for patients in these groups.

• Annals of Surgical Treatment and Research
• /
• 제95권5호
• /
• pp.286-296
• /
• 2018

Purpose: Sentinel lymph node (SLN) biopsy (SLNB) is widely accepted for staging of melanoma patients. It has been shown that clinico-pathological features such as Breslow thickness, ulceration, age, and sex are better predictors of relapse and survival than SLN status alone. The aims of this study were to evaluate the long-term (10-year) prognostic impact of SLNB and to determine predictive factors associated with SLN metastasis, relapse, and melanoma specific mortality (MSM). Methods: This was a prospective observational study on 289 consecutive patients with primary cutaneous melanoma who underwent SLNB from January 2000 to December 2007, and followed until January 2014, at an Italian academic hospital. Results: SLN was positive in 64 patients (22.1%). The median follow-up was 116 months (79-147 months). Tenyear disease-free survival and melanoma specific survival were poor in patients with positive SLN (58.7% and 66.4%, respectively). Only the increasing Breslow thickness resulted independently associated to an increased risk of SLN metastasis. Cox regression analysis showed that a Breslow thickness >2 mm was an independent predictor of relapse, and male sex and Breslow thickness >2 mm was a predictor of MSM. At 10 years, SLN metastasis was not significantly associated to either relapse or MSM. Conclusion: After the fifth year of follow-up, SLN metastasis is not an independent predictive factor of relapse or mortality which are mainly influenced by the characteristics of the primary tumor and of the patient. Patients with a Breslow thickness >2 mm regardless of the SLN status should be considered at high risk for 10-year relapse and mortality.

• 직업교육연구
• /
• 제35권6호
• /
• pp.39-63
• /
• 2016

이 연구의 목적은 실업자가 훈련프로그램을 수료한 이후에 실업자의 실제적인 취업률과 고용유지율에 영향을 미치는 변인을 구명하는 데 있었다. 이를 위해 2012년 훈련서비스 품질 등에 관한 설문조사에 응답한 국가기간 전략산업직종(이하 '기간전략') 훈련생(889명) 중에서 최종적으로 수료한 훈련생(840명)의 훈련과정 종료 후 2년 이상의 고용보험 가입여부 및 가입기간 등에 관한 자료를 활용하여 생존분석(생명표 분석, Cox 회귀모형 분석)을 실시하였다. 이 연구의 주요 결과는 첫째, 수료 후 취업률이 가장 높은(36.8%) 시기는 3개월 이내이고, 전체 훈련생의 50% 이상이 취업한 시기는 6개월 이내로 나타났다. 수료 후 1년과 2년이 경과된 시점까지도 지속적으로 취업이 발생하고 있지만, 시간이 지날수록 취업률은 점점 감소하는 것으로 나타났다. 둘째, 수료 후 취업률에 영향을 미치는 변인은 훈련서비스 품질 중 교수역량(-)과 고용가능성(+)으로, 교수역량을 낮게 인식할수록, 자신의 고용가능성을 높게 인식할수록 취업확률이 높게 나타났다. 셋째, 취업 후 고용상실률이 가장 높은(각 22.0%, 22.3%) 시기는 3개월 이내와 3~6개월 이내이고, 전체 훈련생의 50% 이상이 고용보험을 상실한 시기는 8.8개월 이내로 나타났다. 넷째, 취업 후 고용유지율에 영향을 미치는 변인은 훈련서비스 품질 중 교사-학생관계(+), 학우관계(+), 훈련만족도(+)로, 교사-학생관계와 학우관계의 품질을 높게 인식할수록, 훈련만족도를 높게 인식할수록 취업 후 고용유지확률이 높게 나타났다.

• 사회복지연구
• /
• 제48권4호
• /
• pp.221-249
• /
• 2017

본 연구는 산재근로자들의 직업복귀 형태에 따른 고용유지 기간에 미치는 영향을 실증적으로 규명함으로써 원직복귀 시에는 고용을 유지할 수 있는 방안, 원직복귀에 실패한 경우에는 어떠한 대상을 우선적으로 개입해야 하는지에 대한 방안을 제시하는 데에 목적이 있다. 이를 위해 선행연구 고찰을 바탕으로 한 영향요인을 구성하고, 이를 산재보험패널조사 내에 1,292명을 분석함으로써 각 요인을 파악하였다. 분석결과, 원직복귀집단의 경우 평균 46.6개월, 타직복귀집단의 경우 평균 34.2개월 동안 고용을 유지하고 있는 것으로 나타났다. 또한, 타직복귀가 원직복귀에 비해 여러 번 실업을 경험하는 것으로 나타났으며, 기타 일반적 특성에서도 열악한 노동시장 환경임을 확인하였다. 실증분석 결과, 두 집단 모두 직업복귀기간이 길수록 지속적인 고용을 유지하고 있는 것으로 나타났다. 또한, 타직복귀 시 연령이 낮을수록, 요양기간이 짧을수록, 전반적인 건강상태가 좋지 않은 경우일수록, 사회심리재활서비스, 교육 훈련 및 직업훈련을 경험한 경우 고용유지확률이 높게 나타났다. 이를 토대로 직업복귀기간의 적절한 유예기간 설정과 재해 당시 근로환경이 열악한 근로자의 원직복귀 혹은 산재보상 및 재활서비스 우선적 개입, 산재근로자의 직장복귀 성공 이후에도 사례관리 등을 통한 산재재활서비스의 적극적인 홍보 등을 정책 대안으로 제시하였다.

• 한국식품과학회지
• /
• 제50권6호
• /
• pp.642-652
• /
• 2018

본 연구는 LPS 처리 큰포식 세포에서 옻 추출물, 옻 첨가 된장 및 간장 추출물의 항염증 및 산화방지 효과를 확인하였다. 염증 반응은 자극이 가해지면 히스타민, 세로토닌, 프로스타글란딘과 같은 혈관 활성물질에 의해 혈관 투과성이 증대되어 염증을 유발하고 사이토카인, 활성산소종, lysosomal enzyme 등 다양한 매개 인자가 관여한다. 자극에 의한 큰포식세포의 염증반응은 $TNF-{\alpha}$, IL-6, $IL-1{\beta}$와 같은 pro-inflammatory cytokine의 발현이 유도되고, iNOS와 COX-2에 영향을 받는 유전자의 발현을 자극하게 되어 NO 및 $PGE_2$ 등의 염증 인자가 생성된다. 이에 따라 옻 추출물, 옻 첨가 된장 및 간장 추추물의 염증 및 산화방지시스템 관련 유전자 발현을 분석하였다. 그 결과 옻 추출물은 LPS 자극에 의해 생성된 NO, 염증성 사이토카인 및 $PGE_2$의 생성을 유의적으로 감소시켰다. 옻 추출물은 산화방지관련 핵 내 전사인자인 Nrf2 및 관련 유전자의 발현에 영향을 미치지 않았다. 옻첨가 된장 및 간장 추출물은 NO 및 염증성 사이토카인의 생성을 억제하였지만, 염증 및 산화방지관련 유전자의 발현에 영향을 미치지는 않았다.

• Journal of Chest Surgery
• /
• 제52권4호
• /
• pp.221-226
• /
• 2019

Background: Accurate mediastinal lymph node staging is vital for the optimal therapy and prognostication of patients with lung cancer. This study aimed to determine the preoperative risk factors for pN2 disease, as well as its incidence and long-term outcomes, in patients with clinical N0-1 non-small cell lung cancer. Methods: We retrospectively analyzed patients who were treated surgically for primary non-small cell lung cancer from November 2005 to December 2014. Patients staged as clinical N0-1 via chest computed tomography (CT) and positron emission tomography (PET)-CT were divided into two groups (pN0-1 and pN2) and compared. Results: In a univariate analysis, the significant preoperative risk factors for pN2 included a large tumor size (p=0.083), high maximum standard uptake value on PET (p<0.001), and central location of the tumor (p<0.001). In a multivariate analysis, central location of the tumor (p<0.001) remained a significant preoperative risk factor for pN2 status. The 5-year overall survival rates were 75% and 22.9% in the pN0-1 and pN2 groups, respectively, and 50% and 78.2% in the patients with centrally located and peripherally located tumors, respectively. In a Cox proportional hazard model, central location of the tumor increased the risk of death by 3.4-fold (p<0.001). Conclusion: More invasive procedures should be considered when preoperative risk factors are identified in order to improve the efficacy of diagnostic and therapeutic plans and, consequently, the patient's prognosis.

• Journal of Breast Disease
• /
• 제6권2호
• /
• pp.60-72
• /
• 2018

Purpose: According to American Society of Clinical Oncology/College of American Pathologists guidelines, breast cancer is human epidermal growth factor receptor 2 (HER2) positive if there is HER2 protein overexpression at a 3+ level on immunohistochemistry (IHC 3+) or gene amplification (more than six copies per nucleus) on fluorescence in situ hybridization (FISH+). However, there have been few reports on whether outcomes differ based on diagnosis by these two techniques. In this study, we compared outcomes based on the two methods in patients with HER2-positive breast cancer. Methods: This study was a retrospective analysis of HER2-positive breast cancer in 18,304 patients, including 14,652 IHC 3+ patients and 3,652 FISH+ patients from the Korean Breast Cancer Society Registry. We compared breast cancer-specific survival and overall survival based on IHC 3+ and FISH+ status with or without trastuzumab. Results: Breast cancer-specific survival was significantly different between the IHC 3+ and FISH+ groups, with 5-year cumulative survival rates of 95.0% for IHC 3+ and 98.5% for FISH+ patients who did not receive trastuzumab (p=0.001) in Kaplan-Meier methods. However, there were no significant differences in breast cancer-specific survival and overall survival between IHC 3+ and FISH+ groups regardless of trastuzumab treatment in Cox proportional hazards models. Conclusion: The survival outcomes were not affected by the different two diagnostic methods of HER2-positive breast cancer. Further research to evaluate differences in prognosis and other characteristics according to the diagnostic methods of HER2 positivity is needed in the future.

• Korean Journal of Radiology
• /
• 제19권6호
• /
• pp.1089-1098
• /
• 2018

Objective: To investigate the diagnostic yield of contrast-enhanced computed tomography (CT) in Crohn's disease (CD) patients presenting with acute severe lower gastrointestinal bleeding (LGIB), and the role of CT in predicting the risk of rebleeding. Materials and Methods: A consecutive series of 110 CD patients presenting with acute severe LGIB between 2005 and 2016 were analyzed. Among them, 86 patients who had undergone contrast-enhanced CT constituted the study cohort. The diagnostic yield of CT for detecting contrast extravasation was obtained for the entire cohort and compared between different CT techniques. In a subgroup of 62 patients who had undergone CT enterography (CTE) and showed a negative result for extravasation on CTE, the association between various clinical and CTE parameters and the risk of rebleeding during subsequent follow-up was investigated using Cox regression analysis. Results: The diagnostic yield of CT was 10.5% (9 of 86 patients). The yield did not significantly differ between single-phase and multiphase examinations (p > 0.999), or between non-enterographic CT and CTE (p = 0.388). Extensive CD (adjusted hazard ratio [HR], 3.27; 95% confidence interval [CI], 1.09-9.80; p = 0.034) and bowel wall-to-artery enhancement ratio (adjusted HR, 2.81; 95% CI, 1.21-6.54; p = 0.016) were significantly independently associated with increased rebleeding risks, whereas anti-tumor necrosis factor-${\alpha}$ therapy after the bleeding independently decreased the risk of rebleeding (adjusted HR, 0.26; 95% CI, 0.07-0.95; p = 0.041). Conclusion: The diagnostic yield of contrast-enhanced CT was not high in CD patients presenting with acute severe LGIB. Nevertheless, even a negative CTE may be beneficial as it can help predict the risk of later rebleeding.

• 대한영양사협회학술지
• /
• 제25권3호
• /
• pp.217-228
• /
• 2019

There have been no published studies concerning the anti-inflammatory effects of corn silk on colon cancer cells. Thus, this study was conducted to investigate the effect of corn silk extract containing high levels of maysin on inflammation and its mechanism of action in colon cancer cells. SW 480 human colon cancer cells were treated with $1{\mu}g/mL$ of lipopolysaccharide (LPS) to induce inflammation, and next they were treated with different concentrations of corn silk extract (0, 5, 10 and $15{\mu}g/mL$). The concentrations of nitric oxide (NO) were determined. The mRNA expressions of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor ${\alpha}$ ($TNF-{\alpha}$), interleukin-1beta ($IL-1{\beta}$) and interleukin-6 (IL-6), were determined. Western blot analysis was performed to determine the protein expressions of nuclear factor-kappa B ($NF-{\kappa}B$) and mitogen-activated protein kinases, and the latter consists of extracellular signal-related kinase (ERK), c-jun NH2-terminal kinase (JNK) and p38 MAP kinase (p38). The concentration of NO and the mRNA expression of iNOS were significantly and dose-dependently decreased in the corn silk-treated groups (P<0.05). The mRNA expression of $TNF-{\alpha}$, $IL-1{\beta}$ and IL-6 were significantly increased in the LPS-treated group (P<0.05), but these expressions were significantly and dose-dependently decreased in the corn silk treated groups (P<0.05). The protein expressions of $NF-{\kappa}B$ (in a dose-dependent fashion), ERK (at 10 and $15{\mu}g/mL$), JNK (at $15{\mu}g/mL$) and p38 (at 10 and $15{\mu}g/mL$) were significantly decreased with corn silk treatments (P<0.05). In conclusion, corn silk extract containing high levels of maysin seems to inhibit the LPS-induced inflammatory responses in SW480 colon cancer cells via the $NF-{\kappa}B$ pathway.